Screener
Kura Oncology KURA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | March 31, 2026 | December 31,2025 |
|---|---|---|
| Short-term investments | 541,740 | 518,141 |
| Accounts receivable, net | 9,348 | 8,804 |
| Inventory | 843 | 413 |
| Prepaid expenses and other current assets | 32,768 | 32,206 |
| Total current assets | 623,782 | 708,663 |
| Property and equipment, net | 7,613 | 7,855 |
| Operating lease right-of-use assets | 7,166 | 7,302 |
| Other long-term assets | 13,990 | 14,543 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's prepaid & other current?
- Kura Oncology (KURA) reported prepaid & other current of $32.77M in Q1 2026.
- How has Kura Oncology's prepaid & other current changed year-over-year?
- Kura Oncology's prepaid & other current increased by 89.8% year-over-year, from $17.26M to $32.77M.
- What is the long-term trend for Kura Oncology's prepaid & other current?
- Over 5 years (2020 to 2025), Kura Oncology's prepaid & other current has grown at a 52.0% compound annual growth rate (CAGR), from $3.97M to $32.21M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Kura Oncology's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude